This two-day national symposium addresses recent advances in the field and should be an exciting forum for discussion and debate on the current understanding of cancer and inflammation. The conference, sponsored by the Center of Excellence in Immunology (USA) includes sessions about ‘Inflammation and Microbiota’, ‘Cancer, Microbiota and Metabolism’, ‘miRNAs, Cancer and Inflammation’ and ‘Cancer, Inflammation and Immunity’.
- Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
- A synthetic consortium of 100 gut commensals modulates the composition and function in a colon model of the microbiome of elderly subjects
- ‘Multi-kingdom dialogue’ between internal, external microbiota
- Gut microbiota-derived short-chain fatty acids promote prostate cancer growth via IGF-1 signaling
- Diet alters entero-mammary signaling to regulate the breast microbiome and tumorigenesis